Skip to main content
. 2020 Aug 28;15:209. doi: 10.1186/s13014-020-01653-w

Table 2.

Summary of clinical findings

Parameter No. of patients (%)
Response (n = 25)
 Pathologic complete response 1 (4.0%)
 Clinical complete response 2 (8.0%)
 Partial response 6 (24.0%)
 Stable disease 10 (40.0%)
 Progressive disease 6 (24.0%)
Symptom relief (n = 16)
 Complete relief 9 (56.3%)
 Partial relief 6 (37.5%)
 No relief 1 (6.2%)